Abstract LB327: Discovery and characterization of ABSK112, a next-generation and potential best-in-class EGFR Exon20 mutant inhibitor with superior selectivity and brain penetration ability

Authors: Mei Ning, Shuqun Yang, Juan Peng, Shuangyun Hu, Weijia Lu, Cheng Dai, Baowei Zhao, Mingming Zhang, Hongping Yu, Zhui Chen, Yao-chang Xu

Published: 2023-04-14

DOI: 10.1158/1538-7445.am2023-lb327

Source: Full article